NVision: The Future of Metabolic Imaging NVision is a German quantum technology company advancing metabolic imaging by adding a metabolic layer to standard MRI. While anatomical imaging provides structural information, our POLARIS platform enables visualization of metabolic conversion in real time. POLARIS produces metabolic MRI imaging probes via hyperpolarization, supporting non-invasive investigation of tumor metabolism, including glycolytic activity and hypoxia. These key metabolic biomarkers offer potential research applications across the full radiotherapy workflow, from metabolic characterization and treatment planning to monitoring metabolic patterns following treatment. Our POLARIS platform is currently available for preclinical use. A clinical system is under development.